Do you want to read an article? Please log in or register.
Pulmonary rehabilitation in idiopathic pulmonary fibrosis and COPD: a propensity matched real-world study
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
COPDBronchi
Pulmonary rehabilitation in bronchiectasis: a propensity matched study
Eur Respir J.
Patel S, Cole AD, Nolan CM, Barker RE, Jones SE, Kon S, Cairn J, Loebinger M, Wilson R, Man WD
doi: 10.1183/13993003.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Tomassetti S, Ravaglia C, Wells AU, Cavazza A, Colby TV, Rossi G, Ley B, Ryu JH, Puglisi S, Arcadu A, Marchi M, Sultani F, Martinello S, Donati L, Gurioli C, Gurioli C, Tantalocco P, Hetzel J, Dubini A, Piciucchi S, Klersy C, Lavorini F, Poletti V
doi: 10.1016/S2213-2600(20)30122-3.
RECOMMENDED
COPD
Digitalizing multidisciplinary pulmonary rehabilitation in COPD with a smartphone application: an international observational pilot study
Int J Chron Obstruct Pulmon Dis.
Rassouli F, Boutellier D, Duss J, Huber S, Brutsche MH
doi: 10.2147/COPD.S182880.
RECOMMENDED
Pulmonary Fibrosis
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Duckworth A, Gibbons MA, Allen RJ, Almond H, Beaumont RN, Wood AR, Lunnon K, Lindsay MA, Wain LV, Tyrrell J, Scotton CJ
doi: 10.1016/S2213-2600(20)30364-7.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
COPD
Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Patel S, Palmer MD, Nolan CM, Barker RE, Walsh JA, Wynne SC, Jones SE, Shannon H, Hopkinson NS, Kon SSC, Gao W, Maddocks M, Man WD
doi: 10.1136/thoraxjnl-2020-215281.Visit the original publication at ncbi.nlm.nih.gov
Pulmonary Fibrosis
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
EBioMedicine.
Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, Hashmi SK, Prata L, Masternak MM, Kritchevsky SB, Musi N, Kirkland JL
doi: 10.1016/j.ebiom.2018.12.052.
Pulmonary Fibrosis
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis
Respir Med.
Vancheri C, Sebastiani A, Tomassetti S, Pesci A, Rogliani P, Tavanti L, Luppi F, Harari S, Rottoli P, Ghirardini A, Kirchgaessler KU, Albera C
doi: 10.1016/j.rmed.2019.08.006.
Pulmonary Fibrosis
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
Lancet Respir Med.
Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PL, Braybrooke R, Divyateja H, Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins RG
doi: 10.1016/
RECOMMENDED
COPDPneumonia
Real world effects of COPD medications: a cohort study with validation against RCT results
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Wing K, Williamson E, Carpenter JR, Wise L, Schneeweiss S, Smeeth L, Quint JK, Douglas I
doi: 10.1183/13993003.01586-2020. Visit the original publication at ncbi.nlm.nih.gov